| Product | Code | ||
|---|---|---|---|
| FLJ39303 Antibody (C-term) | AP19134b | 400 µl |
Contact us |
| ZNF733 Antibody (Center) | AP19214c | 400 µl |
Contact us |
| LOC440330 Antibody (C-term) | AP19317b | 400 µl |
Contact us |
| Drh-1 Antibody (N-term) | AP1962a | 400 µl |
Contact us |
| Rde-1 Antibody (N-term) | AP1964a | 400 µl |
Contact us |
| TKT4M Antibody (C-term) | AP5281b | 400 µl |
Contact us |
| hCG_1657980 Antibody (Center) | AP12110c | 400 µl |
Contact us |
| JARID1A Antibody (C-term) | AP12258b | 400 µl |
Contact us |
| LOC728597 Antibody (C-term) | AP12441b | 400 µl |
Contact us |
| PRPS1/PRPS2/PRPS3 Antibody (C-term) | AP7178a | 400 µl |
Contact us |
| Ubiquitin Antibody | AP1229b | 400 µl |
Contact us |
| GPR89 Antibody (Center) | AP8506c | 400 µl |
Contact us |
Abcepta
Abcepta is a leading manufacturer of primary antibodies with more than fifteen years of experience. We supply quality antibodies and related products drug discovery and academic laboratories worldwide. Our focus is on targets covering the major research areas impacting health and disease, including cancer, metabolism, cardiovascular, neuroscience, and stem cells.
More information?Contact Us by e-mail info@divbio.eu
Abcepta
Abcepta is a leading manufacturer of primary antibodies with more than fifteen years of experience. We supply quality antibodies and related products drug discovery and academic laboratories worldwide. Our focus is on targets covering the major research areas impacting health and disease, including cancer, metabolism, cardiovascular, neuroscience, and stem cells.
More information? Contact Us by e-mail info@divbio.co.za
Applied Biological Materials (ABM)
Applied Biological Materials (ABM) Inc. is a Canadian company that is constantly on the lookout for the latest innovations for life science research and drug development. ABM Inc. develops and markets novel products and services to researchers who want the highest quality at the most competitive pricing. Our numerous product lines comprehensively cover many cutting-edge technologies, such as RT-PCR, antibodies, siRNA, cell immortalization, and adenoviral and lentiviral expression systems. We also offer various custom services to create novel solutions to experimental challenges and to help you maximize your time by minimizing your research workload.
More information? Contact Us by e-mail info@divbio.de